BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19292815)

  • 1. Isolated tumor cells in bone marrow and its relation with known prognostic factors in breast cancer patients.
    Sánchez R; González L; Betancourt L; Rodríguez JJ; Sánchez A; Spinetti D; Parada D; Melone S
    Breast J; 2009; 15(2):212-3. PubMed ID: 19292815
    [No Abstract]   [Full Text] [Related]  

  • 2. [Micrometastases in bone marrow at the time of primary treatment of breast cancer: a new prognostic criterion?].
    Untch M; Harbeck N; Eiermann W
    Gynakol Rundsch; 1989; 29 Suppl 2():231-3. PubMed ID: 2693244
    [No Abstract]   [Full Text] [Related]  

  • 3. Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies.
    Amir E; Ooi WS; Simmons C; Kahn H; Christakis M; Popovic S; Kalina M; Chesney A; Singh G; Clemons M
    Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):763-8. PubMed ID: 18824337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Occult multicentric breast cancer].
    Vtorushin SV; Zab'ialova MV; Glushchenko SA; Perel'muter VM; Slonimskaia EM
    Vopr Onkol; 2009; 55(1):38-41. PubMed ID: 19435197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated tumor cells in bone marrow of early-stage breast cancer patients.
    Singletary SE
    J Am Coll Surg; 2006 Aug; 203(2):240-9; quiz A58-9. PubMed ID: 16864036
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of definition of receptor status in the prognosis and the choice of adequate treatment tactics of breast tumors].
    Abuladze TZ; Nemsadze GG; Gersamiia GK
    Georgian Med News; 2006 Aug; (137):22-4. PubMed ID: 16980736
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical significance of disseminated tumor cells in breast cancer.
    Slade MJ; Coombes RC
    Nat Clin Pract Oncol; 2007 Jan; 4(1):30-41. PubMed ID: 17183354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated tumor cells versus micrometastasis: definitions and problems.
    Hermanek P
    Anticancer Res; 1999; 19(4A):2771-4. PubMed ID: 10470239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow metastases in breast cancer.
    Pikarsky E; Peretz T
    N Engl J Med; 2000 Aug; 343(8):577-8. PubMed ID: 10979783
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone marrow metastases in breast cancer.
    Diaz-Cano SJ
    N Engl J Med; 2000 Aug; 343(8):577; author reply 578. PubMed ID: 10979781
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone marrow metastases in breast cancer.
    Funke I; Schraut W
    N Engl J Med; 2000 Aug; 343(8):577; author reply 578. PubMed ID: 10979782
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular markers in the diagnosis and staging of breast cancer.
    Dillon DA
    Semin Radiat Oncol; 2002 Oct; 12(4):305-18. PubMed ID: 12382189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. It is not time to stop progesterone receptor testing in breast cancer.
    Colomer R; Beltran M; Dorcas J; Cortes-Funes H; Hornedo J; Valentin V; Vargas C; Mendiola C; Ciruelos E
    J Clin Oncol; 2005 Jun; 23(16):3868-9; author reply 3869-70. PubMed ID: 15923595
    [No Abstract]   [Full Text] [Related]  

  • 14. Time to stop progesterone receptor testing in breast cancer management.
    Olivotto IA; Truong PT; Speers CH; Bernstein V; Allan SJ; Kelly SJ; Lesperance ML
    J Clin Oncol; 2004 May; 22(9):1769-70. PubMed ID: 15118010
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cancer cells in peripheral lymph and blood and their effect on the morbidity of patients with breast cancer].
    Putyrskiĭ LA
    Ross Med Zh; 1992; (4):39-42. PubMed ID: 1521020
    [No Abstract]   [Full Text] [Related]  

  • 16. Carcinoma of the breast: part 2, prognostic factors and staging.
    Elias EG
    Md State Med J; 1981 Nov; 30(11):35-7. PubMed ID: 7339288
    [No Abstract]   [Full Text] [Related]  

  • 17. [Importance of occult metastatic cells in the treatment of patients with breast and gastrointestinal cancers].
    Braun S; Auer M; Rosenberg R
    Acta Med Austriaca Suppl; 2002; 59():18-26. PubMed ID: 12506756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presenting features of breast cancer differ by molecular subtype.
    Wiechmann L; Sampson M; Stempel M; Jacks LM; Patil SM; King T; Morrow M
    Ann Surg Oncol; 2009 Oct; 16(10):2705-10. PubMed ID: 19593632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to breast-cancer staging.
    Smith BL
    N Engl J Med; 2000 Feb; 342(8):580-1. PubMed ID: 10684918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.